Baricitinib for COVID-19: a suitable treatment?

Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • Antiviral Agents*
  • Azetidines
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2
  • Sulfonamides

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Azetidines
  • Sulfonamides
  • baricitinib